Carotenoid derivatives inhibit nuclear factor kappa B activity in bone and cancer cells by targeting key thiol groups - ScienceDirect
Expression Of Intracellular Components of the NF-κB Alternative Pathway (NF-κB2, RelB, NIK and Bcl3) is Associated With Clinical Outcome of NSCLC Patients | Scientific Reports
Is NF-κB a good target for cancer therapy? Hopes and pitfalls | Nature Reviews Drug Discovery
NF-κB, inflammation, immunity and cancer: coming of age | Nature Reviews Immunology
Genistein as a regulator of signaling pathways and microRNAs in different types of cancers | Cancer Cell International | Full Text
PDF] Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB. | Semantic Scholar
Events following the activation of nuclear factor kappa B (NF-κB) in... | Download Scientific Diagram
Nuclear Factor Kappa B Pathway and human cancer therapeutics
NF-κB inhibitors in treatment and prevention of lung cancer - ScienceDirect
Regulation of Nuclear Factor-KappaB (NF-κB) signaling pathway by non-coding RNAs in cancer: Inhibiting or promoting carcinogenesis? - ScienceDirect
NF-κB inhibitors in treatment and prevention of lung cancer - ScienceDirect
Chronic inflammation and cancer: potential chemoprevention through nuclear factor kappa B and p53 mutual antagonism – ScienceOpen
Frontiers | Targeting Nuclear Factor-Kappa B to Overcome Resistance to Chemotherapy
The Combination of Nuclear Factor Kappa B, Cyclo-oxygenase- 2 and Vascular Endothelial Growth Factor Expression Predicts Poor Pr
The nuclear factor-kappa B pathway and response to treatment in breast cancer | Pharmacogenomics
NF-κB, inflammation, immunity and cancer: coming of age | Nature Reviews Immunology